IDEAYA Biosciences, Inc.
IDYA
$24.82
-$0.04-0.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 4.71% | -49.43% | |||
| Gross Profit | -4.71% | 46.78% | |||
| SG&A Expenses | 7.98% | 23.26% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.23% | -44.16% | |||
| Operating Income | -5.23% | 41.45% | |||
| Income Before Tax | -7.36% | 44.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.36% | 44.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.36% | 44.61% | |||
| EBIT | -5.23% | 41.45% | |||
| EBITDA | -5.13% | 41.64% | |||
| EPS Basic | -7.22% | 45.25% | |||
| Normalized Basic EPS | -7.21% | 53.53% | |||
| EPS Diluted | -7.22% | 45.25% | |||
| Normalized Diluted EPS | -7.21% | 53.53% | |||
| Average Basic Shares Outstanding | 0.13% | 1.16% | |||
| Average Diluted Shares Outstanding | 0.13% | 1.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||